Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer

Despite some therapeutic advances, improvement in survival rates of unresectable and/or metastatic pancreatic ductal adenocarcinoma (PDAC) has been minimal over recent decade. We aimed to evaluate the impact o...

Source: BMC Cancer - January 12, 2024 Category: Cancer & Oncology Authors: Mengjiao Fan, Guochao Deng, Yue Ma, Haiyan Si, Zhikuan Wang and Guanghai Dai Tags: Research Source Type: research